6 ST JOHNS LANE, FLOOR 5, NEW YORK, NY
Chairman Resignation - Miles Suk Steps Down from Abpro Holdings, Inc.
CEO Departure - Miles Suk Resigns; M. Fatih Karatas Appointed Interim CEO
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Material disclosure
Director Resignations - Anthony D. Eisenberg and Sooyoung Lee Step Down
Abpro Holdings Enters $147,000 Loan Agreement with CEO Miles J.W. Suk
Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72
Q1
Notice of Late Filing for Quarterly Report
Amended Annual Report
FY 2025
Notice of Late Filing for Annual Report
Q3
Q2
Effectiveness Notice
Amended Registration Statement for Securities
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement
SEC Staff Correspondence